Abstract:Aims: This study was conducted to explore the high-intensity focused ultrasound (HIFU) prepared antigen-sensitized dendritic cells (DC) and the induction of cytotoxic T lymphocyte (CTL) killing effects by DC and to observe their anti-tumor immunity effects on BALB/c mice. Methods and material: GM-CSF and IL-4 were used to culture the mouse bone marrow-derived DC. HIFU was used to prepare CT-26 tumor cell antigen-sensitive DC vaccines. The capability of T cell proliferation was detected by 3H-TdR, and the CTL cytotoxicity was detected using standard 4h51Cr release assay. The DC-based tumor vaccine prepared using HIFU irradiation was given to normal BALB/c mice. The mice were injected with CT-26 cancer cells subcutaneously seven days later. Further, the occurrence time of the tumor, its weight and volume on the 20th day was observed, and the allergic DC group challenged using repeated-freezing-thawing method alone with the normal saline control group (negative control group) were used to compare group differences. Results: DC in the HIFU group, tumor cell freeze-thawing group, tumor supernatant group, and phosphate buffer solution (PBS) group could induce T cell proliferation in vitro. However, the ability to induce T cell proliferation of DC in the HIFU group and tumor cell freeze-thawing group was significantly higher than those in the tumor supernatant and PBS groups (P < 0. 05). CTL induced in vitro by DC in the HIFU group, and the tumor cell freeze-thawing group had significant cytotoxicity to colon cancer, being significantly different from those in the tumor supernatant and PBS groups (P < 0.05). There was no significant difference between the cytotoxicity of CTL induced in vitro in the HIFU group and the tumor cell freeze-thawing group (P > 0.05). Additionally, significant differences in the occurrence time of the tumor, its weight and volume on the 20th day, and the median survival time of mice among the HIFU group, the repeated-freezing-thawing group, and the negative control group were observed (P < 0.01 or P < 0.05). There was a significant difference between the HIFU and the repeated-freezing-thawing group (P < 0.05). Conclusions: HIFU prepared antigen-sensitized DC could cause substantial proliferation of T cells and CTL with strong anti-tumor effects. The DC-based tumor vaccine prepared using HIFU irradiation affected active immunization on the tumor occurrence in vitro and was better than the DC-based tumor vaccine prepared using the repeated-freezing-thawing method.

In vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigen

Anti-tumor Effect and Its Antigenic Specificity of Cytotoxicity T Lymphocytes Induced by SKOV3 Ovarian Carcinoma Cell Line Freeze-thaw Antigen

In Vitro Study on Cytotoxicity of T Cells Induced by Dendritic Cells Loaded with 6B11 Anti-Idiotypeminibody to Ovarian Cancer Cell Lines

Ovarian carcinoma cells inhibit CD 69 expression in CD 8+T cells

Ovarian Carcinoma Cell Supernatants Inhibit Proliferation and IL-2R Expression of CD8~+ T Cell

An in vitro investigation into the cytotoxic impact of antigen-presenting dendritic cell-tumor infiltrating lymphocytes on ovarian cancer cells

Ovarian carcinoma cells influence differentiation of Lin−CD45RA− dendritic cell precursors into two mature subtypes in vitro

The Anti-Tumor Activity of Dendritic Cell/cytotoxic T Lymphocyte Induced by Cholangiocarcinoma-Derived Exosome and Its Ultrafiltered Lysate

Cytotoxicity of peripheral blood lymphocyte-mediated by an anti-human ovarian carcinoma-anti-human CD3 bispecific single-chain antibody(BHL-I)in vitro and its mechanisms

Ovarian caremoma cell supernatants inhibit proliferation and IL-2R expression of CD8+ T cell

Ovarian Carcinoma Cells Effectively Inhibit Differentiation and Maturation of Dendritic Cells Derived from Hematopoietic Progenitor Cells in Vitro

Conversion of Peripheral CD4+ CD25- Naive T Cells to CD4+ CD25+ Regulatory T Cells by Ovarian Carcinoma Cell Supernatants

Proportion of CD4 CD25 Regulatory T Cell is Increased in the Patients with Ovarian Carcinoma

Dendritic Cells Loaded with Ultrasound-Ablated Tumour Induce in Vivo Specific Antitumour Immune Responses

Ovarian carcinoma cells inhibit ζ chain expression and the secretion of Tc1/Tc2 type cytokines in CD8 + T cells

Experimental study on the induction of cytotoxic T lymphocyte killing effects and dendritic-cell-based tumor vaccine prepared by high-intensity focused ultrasound

Ovarian Carcinoma Cells Inhibit T Cell Proliferation: Suppression of IL-2 Receptor Β and Γ Expression and Their JAK-STAT Signaling Pathway

Study on Tumor-Specific Cytotoxicity T Lymphocytes Activated by Dendritic Cells Loaded with Apoptotic Tumor Cells

In vivo anti-tumor effect of tumor cell-derived exosomes combined with BCG

In Vivo and in Vitro Activation of CTL by Murine Dendritic Cells Pulsed with Acid Eluted Tumor Antigen Peptides

Ovarian Cancer Cells Induce Peripheral Mature Dendritic Cells to Differentiate into Macrophagelike Cells in Vitro